• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ACS/ASCO Offer Guidelines for Primary Care Clinicians Caring for Survivors of Breast Cancer

Article

The workgroup that generated the guideline included experts in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing, along with a cancer survivor who provided a patient perspective.

Healthcare providers managing the needs of survivors of breast cancer may not always be aware of the nuances of clinical management that these patients need. With a 90% 5-year survival rate, breast cancer survivors make up nearly 40% of the overall women cancer survivors. To support primary care physicians as they guide patients through their wellness and quality of life (QoL) concerns, the American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) released an updated ACS/ASCO Breast Cancer Survivorship Care Guideline, which, the committee writes in the Journal of Clinical Oncology (JCO), “will provide comprehensive, holistic recommendations specific to post-treatment breast cancer clinical care to help primary care clinicians better manage potential long-term and late effects and to provide timely and appropriate screening and surveillance to improve the overall health and QoL of breast cancer survivors.”

The workgroup included experts in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing, along with a cancer survivor who provided a patient perspective. Of more than a 1000 articles that were reviewed, 237 met the inclusion criteria. The final recommendations were then a compendium of literature-based evidence and expert consensus opinion.

The guideline makes recommendations that address the following:

a. History and physical

b. Screening the breast for local recurrence or a new primary breast cancer

c. Laboratory testing and imaging

d. Signs of recurrence

e. Risk evaluation and genetic counseling

f. Endocrine treatment impacts, ymptom management

a. Cancer screenings in the average-risk patient

a. Body image concerns

b. Lymphedema

c. Cardiotoxicty

d. Cognitive impairment

e. Distress, depression, anxiety

f. Fatigue

g. Bone health

h. Musculoskeletal health

i. Pain and neuropathy

j. Infertility

k. Sexual health

l. Premature menopause/hot flashes

a. Information

b. Obesity

c. Physical activity

d. Nutrition

e. Smoking cessation

a. Survivorship care plan

b. Communication with oncology team

c. Inclusion of family

1. Surveillance for breast cancer recurrence2. Screening for second primary cancers3. Assessment and management of physical and psychosocial long-term and late effects of breast cancer and treatment4. Health promotion5. Care coordination/practice implicationsIn addition to being published in the JCO, the guideline has also been published in CA: A Cancer Journal for Clinicians. Both ACS and ASCO have of course posted these guidelines on the organizations’ respective websites, and the ASCO Practice Implementation Network is ensuring wide distribution of the guideline.

Related Videos
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Video 10 - "Bronchiectasis Exacerbation Management"
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"
Video 13 - "Concluding Thoughts on Ph+ ALL Treatment"
Video 12 - "The Future of Ph+ ALL Treatments"
dr lawrence eichenfield
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
dr krystyn van vliet
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.